Skip to main content
Clinical Trials/NCT04760470
NCT04760470CompletedNot Applicable

Technology-assisted Upper Extremity Rehabilitation in Subjects with Incomplete Cervical Spinal Cord Injury - Randomized Controlled Crossover Trial

University of Helsinki1 site in 1 country20 target enrollmentStarted: April 12, 2021Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
20
Locations
1
Primary Endpoint
Action Research Arm Test (ARAT)

Study Overview

Brief Summary

The aim of the study is to investigate the effects of 6 weeks of technological-assisted rehabilitation on function of upper extremity and hand in subjects with incomplete cervical spinal cord injury.

Detailed Description

In this crossover study, persons with motor incomplete cervical (C2-C8) spinal cord injury (AIS C-D) will be recruited from the Hospital District of Helsinki and Uusimaa. In the first period of the crossover study, other part of the participants will get technological-assisted upper extremity rehabilitation, while the other part of the participants continue their normal lives. The first period is followed by 4-week wash-out period. In the second period, roles of the participants will be switched. The rehabilitation phase lasts for 6 weeks with 3 weekly sessions, each therapy session including at least 30 minutes of technological-assisted upper extremity rehabilitation. Rehabilitation includes passive, active and resistance exercises, and will be carried out by using AMADEO, PABLO and/or DIEGO devices made by Tyromotion.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Crossover
Primary Purpose
Treatment
Masking
Single (Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to 75 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •incomplete motor spinal cord injury (AIS C-D)
  • •injury level C2-C8
  • •time since injury from 1 to 5 years
  • •to be able to sit
  • •motivation and ability to participate in intensive rehabilitation 3 times per week for 6 week period.

Exclusion Criteria

  • •participation in other exercise study or technological-assisted upper extremity study
  • •unlikely completion of intervention and participation in follow up
  • •injuries that prevent training
  • •weak tolerance of intense training
  • •severe joint movement restriction or instability
  • •irreversible muscle contractures
  • •grade 4 on Modified Ashworth Scale in glenohumeral, elbow, wrist and finger joints
  • •recent significant forearm or hand injuries
  • •memory disorder
  • •orthopedic, rheumatic or neurological diseases (other than spinal cord injury) that prevent training

Arms & Interventions

Wait list control

No Intervention

Continue their normal lives.

Technology-assisted upper extremity rehabilitation

Experimental

Technology-assisted upper extremity rehabilitation.

Intervention: Technology-assisted upper extremity rehabilitation (Other)

Outcomes

Primary Outcomes

Action Research Arm Test (ARAT)

Time Frame: 6 weeks,16 weeks, and 6 months

Maximum score is 114 (on a scale from 0 to 114) as the higher score indicate better upper extremity functioning.

Goal Attainment Scaling (GAS)

Time Frame: 6 weeks or 16 weeks

A method to evaluate rehabilitation effects. A 5-point scale ranging from -2 to 2. Zero represents expected level of performance after rehabilitation, +1 more than expected, and +2 much more than expected. Respectively, -1 means less than expected and -2 much less than expected.

Secondary Outcomes

  • American Spinal Injury Association - Upper Extremity Motor Scores (ASIA-UEMS)(6 weeks,16 weeks, and 6 months)
  • Pinch strength(6 weeks,16 weeks, and 6 months)
  • Grip strength(6 weeks,16 weeks, and 6 months)
  • Upper extremity active range of motion(6 weeks,16 weeks, and 6 months)
  • Spinal Cord Independence Measure - Self Report (SCIM-SR)(6 weeks,16 weeks, and 6 months)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Joonas Poutanen

Principal investigator

University of Helsinki

Study Sites (1)

Loading locations...

Similar Trials